Respiratory syncytial virus infection and bronchiolitis

Pediatrics in Review

Volumn 35, Issue 12, 2014, Pages 519-530

  Piedimonte, Giovanni ^a   Perez, Miriam K ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Independence Family Health Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; DRUG; HELIOX; IMMUNOGLOBULIN; MONTELUKAST; MOTAVIZUMAB; PALIVIZUMAB; RESPIRATORY SYNCYTIAL VIRUS VACCINE; SODIUM CHLORIDE; SURFACTANT; VIRUS VACCINE;

ARTICLE; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; ASTHMA; BREATHING EXERCISE; CHILDHOOD DISEASE; CLINICAL FEATURE; ENDOTRACHEAL INTUBATION; HAND WASHING; HUMAN; INFANT DISEASE; META ANALYSIS (TOPIC); NONHUMAN; NUTRITIONAL SUPPORT; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SYSTEMATIC REVIEW (TOPIC); VIRAL BRONCHIOLITIS; VIRUS PATHOGENESIS; WHEEZING; BRONCHIOLITIS, VIRAL; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; PATHOGENICITY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

BRONCHIOLITIS, VIRAL; HUMANS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; VIRAL VACCINES;

EID: 84913533040     PISSN: 01919601     EISSN: 15263347     Source Type: Journal    
DOI: 10.1542/pir.35-12-519     Document Type: Article

References (10)

1. Ralston S, et al. Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis. Pediatrics. 2014;134(5):e1474-e1502. Accessed October 28, 2014, at: http://pediatrics.aappublications.org/content/134/5/e1474.full
2. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375(9725):1545-1555
3. Hall CB, Douglas RG Jr. Modes of transmission of respiratory syncytial virus. J Pediatr. 1981;99(1):100-103
4. Gadomski AM, Bhasale AL. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2006;3(3):CD001266
5. Patel H, Platt R, Lozano JM, Wang EE. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2004; (3):CD004878
6. Ventre K, Randolph AG. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst Rev. 2007; (1):CD000181
7. IMPACT-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998;102(3, pt 1):531-537
8. Sigurs N, Gustafsson PM, Bjarnason R, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med. 2005;171(2):137-141
9. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354(9178):541-545
10. Blanken MO, Rovers MM, Molenaar JM, et al; Dutch RSV Neonatal Network. Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med. 2013;368(19):1791-1799